Trinity Biotech has bought the Washington, US-based diagnostics manufacturer Bartels for $9.3 million (€10.41 million). Founded in 1978, Bartels is a world leader in the development and manufacture of diagnostic products for the identification of infectious agents which are cell dependent.
Trinity Biotech buys Bartels
Trinity Biotech has bought the Washington, US-based diagnostics manufacturer Bartels for $9.3 million (€10.41 million)
IN THIS SECTION
Explainer: 10 takeaways from Cop 29, a collective failure
Springboks extend Wales’ record losing run with victory in Cardiff
Only 319 of 1,500 employment permits for coach drivers are issued
Election 2024 live updates: Party leaders continue campaigns as poll indicates drop in support for Harris and Fine Gael
Wills without residuary clauses can see people inherit even if you didn’t want them to
Business Today
Get the latest business news and commentary from our expert business team in your inbox every weekday morning